The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades for a devastating cancer.

“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

MINNEAPOLIS — A warm, fuzzy feeling can be hard to come by for young adults experiencing homelessness, but for some at Catholic Charities’ Hope Street shelter, it arrived on four legs. Em Lucier has ...

Even the closest of families can be a little dysfunctional—and if you’ve ever been in therapy, you’ve probably complained about yours during a one-on-one session. But what if you could hash out your ...

A Food and Drug Administration (FDA) expert panel is urging loosened restrictions and expanded access to testosterone replacement therapy (TRT). The recommendations follow new large clinical trials ...

Dec 15 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca (AZN.L), opens new tab and partner Daiichi Sankyo's (4568.T), opens new tab Enhertu in combination with Roche's (ROG.S ...

A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. The current standard of care for the ...

Hot flashes and brain fog and lack of sleep—all these symptoms and more await women as they approach and go through menopause. For some, these symptoms can be debilitating and may even start as early ...

Itvisma should only be administered intrathecally using a lumbar puncture by health care professionals experienced in performing the procedure. The Food and Drug Administration has approved Itvisma ® ...